Patients' perceptions of isotretinoin, depression and suicide--a qualitative study.

Magin, P; Adams, J; Heading, G; Pond, D; Smith, W

Patients' perceptions of isotretinoin, depression and suicide--a qualitative study.

Magin, P Adams, J

Heading, G Pond, D Smith, W

Permalink

Publication Type:: Journal Article
Citation:: Australian family physician, 2005, 34 (9), pp. 795 - 797
Issue Date:: 2005-01-01

Closed Access

	Filename	Description	Size
	2010004916OK.pdf		252.9 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Magin, P	en_US
dc.contributor.author	Adams, J https://orcid.org/0000-0002-9901-5717	en_US
dc.contributor.author	Heading, G	en_US
dc.contributor.author	Pond, D	en_US
dc.contributor.author	Smith, W	en_US
dc.date.issued	2005-01-01	en_US
dc.identifier.citation	Australian family physician, 2005, 34 (9), pp. 795 - 797	en_US
dc.identifier.issn	0300-8495	en_US
dc.identifier.uri	http://hdl.handle.net/10453/17120
dc.description.abstract	BACKGROUND: Isotretinoin is an effective acne medication. The evidence for it causing depression and suicide, although widely publicised, remains uncertain. METHODS: Twenty-six semi-structured interviews with patients with acne were coded and subjected to thematic analysis. RESULTS: Isotretinoin was perceived to be effective but dangerous. The most well known adverse effects were depression and suicide. DISCUSSION: The overemphasis of serious psychological adverse events in patients might discourage the use of isotretinoin by those who might benefit from it.	en_US
dc.relation.ispartof	Australian family physician	en_US
dc.subject.classification	General & Internal Medicine	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Abnormalities, Drug-Induced	en_US
dc.subject.mesh	Acne Vulgaris	en_US
dc.subject.mesh	Isotretinoin	en_US
dc.subject.mesh	Health Care Surveys	en_US
dc.subject.mesh	Risk Assessment	en_US
dc.subject.mesh	Health Knowledge, Attitudes, Practice	en_US
dc.subject.mesh	Depression	en_US
dc.subject.mesh	Suicide	en_US
dc.subject.mesh	Qualitative Research	en_US
dc.subject.mesh	Adolescent	en_US
dc.subject.mesh	Adult	en_US
dc.subject.mesh	Middle Aged	en_US
dc.subject.mesh	Female	en_US
dc.subject.mesh	Male	en_US
dc.title	Patients' perceptions of isotretinoin, depression and suicide--a qualitative study.	en_US
dc.type	Journal Article
utslib.citation.volume	9	en_US
utslib.citation.volume	34	en_US
utslib.for	1117 Public Health and Health Services	en_US
utslib.for	1103 Clinical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
utslib.copyright.status	closed_access
pubs.issue	9	en_US
pubs.publication-status	Published	en_US
pubs.volume	34	en_US

Abstract:

BACKGROUND: Isotretinoin is an effective acne medication. The evidence for it causing depression and suicide, although widely publicised, remains uncertain. METHODS: Twenty-six semi-structured interviews with patients with acne were coded and subjected to thematic analysis. RESULTS: Isotretinoin was perceived to be effective but dangerous. The most well known adverse effects were depression and suicide. DISCUSSION: The overemphasis of serious psychological adverse events in patients might discourage the use of isotretinoin by those who might benefit from it.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/17120